Clinical Trials Browser

Completed × Fanconi Anemia, Complementation Group D1 × Gastrointestinal × Clear all

Fanconi Anemia, Complementation Group D1, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

NCT03889171 2019-03-28

PSICOM

BreastClassical hematologyGastrointestinalGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Genetic Predisposition to Disease

NCT01286987 2019-01-10

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Phase 1 Completed

113 enrolled 39 charts

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Fanconi Anemia, Complementation Group D1, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Ewing, Small Cell Lung Carcinoma

Clinical Trials

CAPS 3

PSICOM

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors